PCORI Participants Struggle To Avoid Discussing Cost In Hep C Rx Debate

By John Wilkerson / October 22, 2014 at 5:17 PM
Participants at PCORI's recent meeting on hepatitis C treatments struggled to avoid talking about cost because they said they wouldn't be holding a meeting on the treatments were they not so expensive. The ACA-created Patient-Centered Outcomes Research Institute by law is not allowed to fund research on economic outcomes, but the institute put out an updated guidance last month saying it would consider research on how patients' out-of-pocket costs affect access to care. PCORI met Friday (Oct. 17) to gather...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.